The effect of nisin on murein synthesis
- PMID:6255884
- DOI: 10.1007/BF00427192
The effect of nisin on murein synthesis
Abstract
Nisin inhibits murein synthesis with concomitant accumulation of undecaprenyl-pyrophospho-MurHAc(pentapeptide) (lipid intermediate I). This inhibition is caused by the formation of a complex between the antibiotic and lipid intermediate I. Undecaprenyl-pyrophospho-MurNAc(pentapeptide)-GlcNAc (lipid intermediate II) also forms a complex with nisin. However, when murein synthesis is inhibited by nisin, this latter complex is not formed since lipid intermediate II is not longer synthesized.
Similar articles
- Variations in UDP-N-acetylglucosamine and UDP-N-acetylmuramyl-pentapeptide pools in Escherichia coli after inhibition of protein synthesis.Mengin-Lecreulx D, Siegel E, van Heijenoort J.Mengin-Lecreulx D, et al.J Bacteriol. 1989 Jun;171(6):3282-7. doi: 10.1128/jb.171.6.3282-3287.1989.J Bacteriol. 1989.PMID:2656647Free PMC article.
- Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, Sahl HG.Wiedemann I, et al.J Biol Chem. 2001 Jan 19;276(3):1772-9. doi: 10.1074/jbc.M006770200. Epub 2000 Oct 18.J Biol Chem. 2001.PMID:11038353
- Analysis of murein and murein precursors during antibiotic-induced lysis of Escherichia coli.Kohlrausch U, Höltje JV.Kohlrausch U, et al.J Bacteriol. 1991 Jun;173(11):3425-31. doi: 10.1128/jb.173.11.3425-3431.1991.J Bacteriol. 1991.PMID:2045364Free PMC article.
- Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.de Kruijff B, van Dam V, Breukink E.de Kruijff B, et al.Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):117-21. doi: 10.1016/j.plefa.2008.09.020. Epub 2008 Nov 12.Prostaglandins Leukot Essent Fatty Acids. 2008.PMID:19008088Review.
- The biosynthesis of peptidoglycan lipid-linked intermediates.Bouhss A, Trunkfield AE, Bugg TD, Mengin-Lecreulx D.Bouhss A, et al.FEMS Microbiol Rev. 2008 Mar;32(2):208-33. doi: 10.1111/j.1574-6976.2007.00089.x. Epub 2007 Dec 10.FEMS Microbiol Rev. 2008.PMID:18081839Review.
Cited by
- Biosynthesis of the lantibiotic nisin: genomic organization and membrane localization of the NisB protein.Engelke G, Gutowski-Eckel Z, Hammelmann M, Entian KD.Engelke G, et al.Appl Environ Microbiol. 1992 Nov;58(11):3730-43. doi: 10.1128/aem.58.11.3730-3743.1992.Appl Environ Microbiol. 1992.PMID:1482192Free PMC article.
- Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.Roces C, Rodríguez A, Martínez B.Roces C, et al.Probiotics Antimicrob Proteins. 2012 Dec;4(4):259-72. doi: 10.1007/s12602-012-9116-9.Probiotics Antimicrob Proteins. 2012.PMID:26782186
- Inhibition of peptidoglycan biosynthesis by ramoplanin.Somner EA, Reynolds PE.Somner EA, et al.Antimicrob Agents Chemother. 1990 Mar;34(3):413-9. doi: 10.1128/AAC.34.3.413.Antimicrob Agents Chemother. 1990.PMID:2334153Free PMC article.
- Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.Wiedemann I, Böttiger T, Bonelli RR, Schneider T, Sahl HG, Martínez B.Wiedemann I, et al.Appl Environ Microbiol. 2006 Apr;72(4):2809-14. doi: 10.1128/AEM.72.4.2809-2814.2006.Appl Environ Microbiol. 2006.PMID:16597986Free PMC article.
- Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics.Smith L, Hillman J.Smith L, et al.Curr Opin Microbiol. 2008 Oct;11(5):401-8. doi: 10.1016/j.mib.2008.09.008. Epub 2008 Oct 24.Curr Opin Microbiol. 2008.PMID:18848642Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Other Literature Sources